Although a previous report aimed at understanding the structural impact of some of those mutations in IRE1 function (Xue et al, 2011), little is known on how their differential contribution to RIDD and XBP1 mRNA splicing impacts on GBM development and progression. The gene discussed is ERN1; the disease is glioblastoma.